Pharmaceutical Technology

JUNE 21, 2023

CSL announced the first patient with haemophilia B has been treated with its recently approved gene therapy Hemgenix (etranacogene dezaparvovec). In the study, Hemgenix reduced or eliminated the need for prophylactic treatment in 94% of patients. Hemgenix is the first and only gene therapy approved for haemophilia B.

Patients 98

Patients Food and Drug Administration Sales Engineering 98

European Pharmaceutical Review

JUNE 10, 2024

The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. This news follows the company beginning construction on a similar facility in France , which is set to produce lead-212 radioligand therapies for the European market.

Manufacturing 98

Manufacturing Distribution Pharmaceutical manufacturing Leads 98

Medico Reach

SEPTEMBER 12, 2022

billion by 2030. Upon immediately subjecting the patient to an X-ray, the barium appears white as doctors observe how it outlines the digestive tract. . Option to treat the patient during endoscopy. But since the patient is already sedated while performing the procedure, the doctor can treat the problem during endoscopy.

Marketing 52

Marketing Doctors Training Medical 52

Pharmaceutical Technology

JUNE 7, 2023

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson. of patients’ body weight (52lb or 24kg) and greater than 50% of patients taking Mounjaro achieving at least 20% body weight reductions.

Leads 98

Leads Marketing FDA Sales 98

Pharmaceutical Technology

APRIL 18, 2023

It dissolves rapidly releasing the active ingredient in the mouth, meaning there is no requirement for the patient to swallow a pill. This route of administration makes it a potential alternative, especially for migraine patients who suffer from migraine-related nausea.

Food and Drug Administration 98

Food and Drug Administration FDA Food Marketing 98

Pharmaceutical Technology

FEBRUARY 10, 2023

4DMT had paused enrollment of patients to two of its trials for 4D-310 last month following a significant adverse event where three patients experienced kidney issues; however, these were treated and resolved in a four-week period.

FDA 105

FDA Leads Competition Marketing 105

World of DTC Marketing

DECEMBER 18, 2020

I understand the hard-working people who really believe in what they’re doing for patients, but senior executives continue to bow to Wall Street. When a new drug is on the horizon stories, the effect, the drug will have on its stock price, not on patients. Obesity costs the nation $1.72 trillion every year.

Pharma 155

Pharma Prescription Media Healthcare 155

European Pharmaceutical Review

JANUARY 27, 2023

.” “Efforts to expand access to medicines, especially insulin, are only beneficial when effective cold chain systems are in place to keep them at the right temperature on their way to patients,” commented Leigh Ann Pusey, Executive Vice President of corporate affairs and communications for Lilly.

Distribution 105

Distribution Transportation Medicine Medical 105

European Pharmaceutical Review

MAY 2, 2024

As a result, the market is expected to reach $719 billion by 2030, 1 Sigma Mostafa, PhD, Chief Scientific Officer at KBI Biopharma shared with EPR. What excites me most is the continuous infusion of new modalities, unique conjugates, and enabling technologies leading to more targeted and effective therapies. Bn by 2030.

Medicine 105

Medicine Manufacturing Biopharma Engineering 105

Pharmaceutical Technology

MAY 19, 2023

Multiple sclerosis (MS) is a primary autoimmune disease in which inflammation is a core contributor to the degeneration of the central nervous system (CNS), leading to neurological disability and affecting sensory, visual, motor, and autonomic systems. DMTs for MS have a high price tag, particularly in the US.

Prospecting 98

Prospecting Marketing Patients Leads 98

European Pharmaceutical Review

FEBRUARY 8, 2023

The number of blood cancer patients receiving CD19-directed CAR-T therapies is set to boom over the next decade from approximately 3,700 patients in 2021 to nearly 13,500 patients in 2031. It is set to retain its market-leading position as the most lucrative CD19 CAR-T agent in NHL, with annual sales reaching $1.7

Marketing 98

Marketing Sales Physicians Patients 98

pharmaphorum

JANUARY 6, 2023

The UK has formed an partnership with German biotech BioNTech to provide up to 10,000 patients with access to personalised cancer therapies, in another example of the country embracing the mRNA technologies that underpinned COVID-19 vaccines. If successful, the partnership may also lead to manufacturing investments in the UK.

Manufacturing 111

Manufacturing Patients Leads 111

pharmaphorum

JANUARY 10, 2023

BioNTech’s chief executive Uğur Şahin said the acquisition will help “make BioNTech a technology company where AI is seamlessly integrated into all aspects of our work” as it stives to maintain its leading position in COVID-19 vaccines and continues to builds an oncology pipeline.

Manufacturing 116

Manufacturing Engineering Government Leads 116

pharmaphorum

JANUARY 19, 2023

India’s Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of hair loss. The $11.50 “We are well-positioned to successfully bring this product to market globally,” he added.

Pharma 98

Pharma Marketing FDA Leads 98

European Pharmaceutical Review

SEPTEMBER 7, 2022

billion market by 2030, growing from a 2020 value of around $2.4 However, certain patients perceive the larger capsules required for some multi-API drug products, or those with complex controlled release profiles, as difficult to swallow. This can create challenges in terms of patient compliance.

Pharmaceutical 124

Pharmaceutical Pharma Manufacturing Patients 124

Pharmaceutical Technology

JUNE 30, 2022

By 2030, it strives to “free more than one billion people who currently require interventions against neglected tropical diseases.”. At the moment, ivermectin is the therapeutic used against river blindness, but it cannot kill the adult worm, which effectively means that patients need to seek out treatments regularly, Fraisse explains.

Leads 64

Leads Pharma Medicine FDA 64

LEVO Health

MAY 8, 2024

As healthcare practices strive to navigate the complexities of patient needs and preferences, the importance of fostering robust patient engagement strategies cannot be overstated. The Importance of Patient Engagement Personalization for patients is a key driver of improved healthcare outcomes.

Healthcare 52

Healthcare Healthcare Patients Healthcare Provider 52

Clarivate

AUGUST 17, 2022

In our latest podcast, Ideas to Innovation, we speak with Dr. Grace Lomax, the clinical director at Patient Connect, part of Clarivate. Also listed as a target is reducing premature deaths from non-communicable diseases by one third by 2030. Supporting patients at the point of care. Dr. Grace Lomax.

Healthcare 52

Healthcare Healthcare Patients Physicians 52

Eversana Intouch

OCTOBER 13, 2023

Addressing SDOH is one way that a government program, Healthy People 2030, is trying “improve the health and well-being of all.” Addressing SDOH is one way that a government program, Healthy People 2030, is trying “improve the health and well-being of all.”

Pharma 105

Pharma Education Government Pharmaceutical 105

European Pharmaceutical Review

MARCH 24, 2023

In NASH, excess fat in the liver can lead to progressive disease, including inflammation, liver cell injury and fibrosis, which are associated with increased risk for cardiovascular disease and liver morbidity and mortality. It is becoming the leading cause for liver transplants. How does pegozafermin work in potentially treating NASH?

Medical 108

Medical Side effects Safety Pharmaceutical 108

European Pharmaceutical Review

JUNE 27, 2022

The European Commission (EC) has launched the Healthier Together: EU Non-communicable diseases (NCDs) initiative to support EU Member States in reducing the burden of NCDs by addressing the leading causes of avoidable premature death in Europe and improving citizens’ health and well-being. Did you know, 1.7

Medicine 110

Medicine Healthcare Healthcare Government 110

European Pharmaceutical Review

JANUARY 22, 2024

million by 2030, according to a report by ResearchAndMarkets. Between 2023 to 2030, this represents a CAGR of 15.13 Crititically, they also enable a lower cross-contamination risk, enhancing patient safety. North America was leading the E&L testing services market with a revenue share of 43.71 percent in 2022.

Marketing 52

Marketing Safety Medicine Pharmaceutical 52

Pharmaceutical Technology

AUGUST 26, 2022

This guidance is in line with the WHO’s End TB Strategy, which aims for an 80% fall in worldwide TB incidence and a 90% decrease in TB deaths by 2030, compared with 2015. Each trial will recruit approximately 500 patients. Following this, patients must receive follow-ups to ensure that they do not have a post-treatment relapse.

Side effects 98

Side effects Pharmaceutical Patients Recruitment 98

Medico Reach

OCTOBER 17, 2022

from 2022 to 2030. However, this can lead to several issues, such as: Implantation resistance due to reactionary metabolism Allergic reactions to the nickel component found in stainless steel composites Widespread bone destruction due to immunological responses to cobalt particles. The US-based Enovis is leading this new development.

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

European Pharmaceutical Review

MAY 11, 2023

Notably, data from LT-001, a 15-year ongoing observational study following the Phase I START patients, showed that children treated after presenting symptoms of SMA maintained all previously achieved milestones up to 7.5 By 2030, 20-25 gene therapies are expected to reach market approval, accounting for 1.30-1.61 years post-dosing.

Food and Drug Administration 95

Food and Drug Administration Government Healthcare Healthcare 95

PM360

NOVEMBER 29, 2022

The White House’s recent Health Sector Climate Pledge brought together hospitals and healthcare companies that committed to reduce greenhouse gas emissions 50% by 2030. Extreme temperatures lead to more cases of heat stroke, which can be fatal or lead to chronic health issues.

Healthcare 98

Healthcare Healthcare Manufacturing Pharmaceutical 98

pharmaphorum

NOVEMBER 8, 2022

Taken together, the system can support patients with medication reminders, education resources, insulin dose logging and feedback on blood glucose levels, while a hub for physicians called Tempo Insights to help them make decisions about patient care based on data.

Management 64

Management Marketing Physicians Education 64

pharmaphorum

AUGUST 1, 2022

Ties Kroezen, venture leader of Community Life Centers and business development manager for Philips Africa, tells us about the challenges present within the African healthcare system, solutions the company developed to help patients and providers connect, and how pharma can assist with delivering better care to African residents.

Healthcare 78

Healthcare Healthcare Pharma Government 78

Healthcare Success

JANUARY 2, 2024

Now that the holidays have drawn to a close, it’s time to return to your 2024 marketing plan and make adjustments that ensure your business is taking advantage of the latest trends in healthcare marketing to reach patients and HCPs more effectively and make a lasting impression. health conditions, clinical decisions, spread of disease).

Healthcare 78

Healthcare Healthcare Marketing Healthcare Provider 78

Pharmaceutical Technology

MARCH 29, 2023

This next extension beyond 2030 is a testament to the success and trust of the partnership, as well as to the high degree of confidence placed in our platforms and the complementary approach to generating a leading pipeline of highly innovative drug candidates.

Food and Drug Administration 52

Food and Drug Administration Medicine Food FDA 52

pharmaphorum

SEPTEMBER 16, 2022

UK-based George Medicines is running a phase 3 trial of GMRx2 – a low-dose formulation of established blood pressure drugs telmisartan, amlodipine, and indapamide – involving 1,500 patients across seven countries. By 2030, it is projected that over 215 million Africans will have hypertension.

Side effects 52

Side effects Medicine Healthcare Provider Patients 52

Clarify Health

OCTOBER 12, 2023

After two decades, healthcare is still working to find a better way to reward clinicians for the quality and efficiency of the care they provide rather than for the volume of patients treated. These strategies aim to align the interests of payers and providers to improve patient outcomes while controlling costs.

Healthcare Provider 59

Healthcare Provider Insurance Healthcare Healthcare 59

pharmaphorum

OCTOBER 17, 2022

“Novo Nordisk is proud to lead the industry in sustainable business practices, doing our part to give empty pens new purpose,” said the company’s UK general manager, Pinder Sahota. Novo Nordisk is also working towards zero CO2 emissions from operations and transportation by 2030.

Transportation 64

Transportation Medical Healthcare Healthcare 64

pharmaphorum

JANUARY 24, 2023

For the most commonly used, high volume medicines, countrywide networks of distribution to get them to where patients live, reliably, securely, and regularly, are required. Medicines distribution and supply is also an energy intensive and regulated business. She holds a degree in biochemistry from Oxford University.

Medicine 98

Medicine Healthcare Healthcare Pharma 98

Medico Reach

MARCH 24, 2023

Even for cancers that are difficult to treat, new treatments and technologies improve patient survival rates. To address the shortcomings of existing treatments, routine utilization of patient data becomes crucial. It is further expected to reach USD 14,505 million in 2030. billion by 2030. billion in 2021.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Medico Reach

MARCH 24, 2023

Even for cancers that are difficult to treat, new treatments and technologies improve patient survival rates. To address the shortcomings of existing treatments, routine utilization of patient data becomes crucial. It is further expected to reach USD 14,505 million in 2030. billion by 2030. billion in 2021.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

PM360

SEPTEMBER 7, 2023

Forming synergistic partnerships and working with communities can help create sustainable change because when we “meet” patients where they are, we’ll see the solution probably lies there, too. Partner with local community organizations and leaders, pharmacies, and healthcare clinics that have the trust of their patients.

Healthcare 111

Healthcare Healthcare Patients Marketing 111